Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Moutou, C.
Right arrow Articles by Mandel, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moutou, C.
Right arrow Articles by Mandel, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 971-979, Copyright © 1997 by Oxford University Press


ARTICLES

Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic

C Moutou, MC Vincent, V Biancalana and JL Mandel
Laboratoire de Genetique Moleculaire Humaine, Faculte de Medecine et CHRU, Strasbourg, France.

In the fragile X syndrome, the transition from unmethylated moderate expansions of the CGG repeat (premutations) to methylated large expansions (full mutations) occurs only through maternal transmission. The risk of such transition is highly correlated with the size of the maternal premutation (PM), being very low for small PM alleles (approximately 60 repeats), to 100% for alleles above 100 repeats. The timing of this transition was the object of much speculation. A postzygotic transition was proposed as a preferred model, based on the observation that males with full mutation (FM) have PM in sperm. Analysis of tissues from affected fetuses, including additional data reported here, indicate that such a putative postzygotic transition would have to occur very early in embryogenesis and most likely before determination of germ cell lineage. At least 15% of carriers of a FM show a significant proportion of white blood cells carrying a PM (mutation mosaics). We performed a simulation study showing that, if transition to FM is postzygotic, one should observe a much higher proportion of such mosaics in offspring of mothers with small PMs. This was compared with the actual pattern observed in 212 mutated offspring of 112 PM carrier mothers. We found no effect of maternal PM size on incidence of mosaicism in leucocytes. We propose that this is strong, albeit indirect evidence against a postzygotic transition to FM. A transition at an early morula stage (before day 3) cannot, however, be formally excluded.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
G.-F. Richard, A. Kerrest, and B. Dujon
Comparative Genomics and Molecular Dynamics of DNA Repeats in Eukaryotes
Microbiol. Mol. Biol. Rev., December 1, 2008; 72(4): 686 - 727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. J. Gray, J. Gerhardt, W. Doerfler, L. E. Small, and E. Fanning
An Origin of DNA Replication in the Promoter Region of the Human Fragile X Mental Retardation (FMR1) Gene
Mol. Cell. Biol., January 15, 2007; 27(2): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Savouret, C. Garcia-Cordier, J. Megret, H. te Riele, C. Junien, and G. Gourdon
MSH2-Dependent Germinal CTG Repeat Expansions Are Produced Continuously in Spermatogonia from DM1 Transgenic Mice
Mol. Cell. Biol., January 15, 2004; 24(2): 629 - 637.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-R. Yoon, L. Dubeau, M. de Young, N. S. Wexler, and N. Arnheim
Huntington disease expansion mutations in humans can occur before meiosis is completed
PNAS, July 22, 2003; 100(15): 8834 - 8838.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. L. Liquori, K. Ricker, M. L. Moseley, J. F. Jacobsen, W. Kress, S. L. Naylor, J. W. Day, and L. P. W. Ranum
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Science, August 3, 2001; 293(5531): 864 - 867.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. J. M. Bontekoe, C. E. Bakker, I. M. Nieuwenhuizen, H. van der Linde, H. Lans, D. de Lange, M. C. Hirst, and B. A. Oostra
Instability of a (CGG)98 repeat in the Fmr1 promoter
Hum. Mol. Genet., August 1, 2001; 10(16): 1693 - 1699.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. J. White, R. H. Borts, and M. C. Hirst
Stability of the Human Fragile X (CGG)n Triplet Repeat Array in Saccharomyces cerevisiae Deficient in Aspects of DNA Metabolism
Mol. Cell. Biol., August 1, 1999; 19(8): 5675 - 5684.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A T J M Helderman-van den Enden, P D Maaswinkel-Mooij, E Hoogendoorn, R Willemsen, J A Maat-Kievit, M Losekoot, and B A Oostra
Monozygotic twin brothers with the fragile X syndrome: different CGG repeats and different mental capacities
J. Med. Genet., March 1, 1999; 36(3): 253 - 257.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.